We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
China’s State Food and Drug Administration (SFDA) has issued a final regulation dealing with requirements for on-site verification of drug registration.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor